These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 15477873
1. Proteome analysis of prostate cancer. Kuruma H, Egawa S, Oh-Ishi M, Kodera Y, Maeda T. Prostate Cancer Prostatic Dis; 2005; 8(1):14-21. PubMed ID: 15477873 [Abstract] [Full Text] [Related]
2. Disease proteomics of high-molecular-mass proteins by two-dimensional gel electrophoresis with agarose gels in the first dimension (Agarose 2-DE). Oh-Ishi M, Maeda T. J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr 15; 849(1-2):211-22. PubMed ID: 17141588 [Abstract] [Full Text] [Related]
3. Proteomics for the identification of new prostate cancer biomarkers. Ornstein DK, Tyson DR. Urol Oncol; 2006 Apr 15; 24(3):231-6. PubMed ID: 16678055 [Abstract] [Full Text] [Related]
4. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. Ummanni R, Junker H, Zimmermann U, Venz S, Teller S, Giebel J, Scharf C, Woenckhaus C, Dombrowski F, Walther R. Cancer Lett; 2008 Aug 08; 266(2):171-85. PubMed ID: 18384941 [Abstract] [Full Text] [Related]
5. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T. Proteomics; 2006 Feb 08; 6(3):1011-8. PubMed ID: 16400690 [Abstract] [Full Text] [Related]
6. The evolving role of proteomics in the early detection of breast cancer. Pawlik TM, Kuerer HM. Int J Fertil Womens Med; 2005 Feb 08; 50(5 Pt 1):212-6. PubMed ID: 16468471 [Abstract] [Full Text] [Related]
8. Analysis of prostate cancer by proteomics using tissue specimens. Liu AY, Zhang H, Sorensen CM, Diamond DL. J Urol; 2005 Jan 08; 173(1):73-8. PubMed ID: 15592032 [Abstract] [Full Text] [Related]
9. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. Garbis SD, Tyritzis SI, Roumeliotis T, Zerefos P, Giannopoulou EG, Vlahou A, Kossida S, Diaz J, Vourekas S, Tamvakopoulos C, Pavlakis K, Sanoudou D, Constantinides CA. J Proteome Res; 2008 Aug 08; 7(8):3146-58. PubMed ID: 18553995 [Abstract] [Full Text] [Related]
12. What can proteomic analyses contribute to understanding the molecular biology and clinical behavior of prostate cancer? Ware JL. Expert Rev Proteomics; 2004 Dec 08; 1(4):485-92. PubMed ID: 15966843 [Abstract] [Full Text] [Related]
14. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry. Lee IN, Chen CH, Sheu JC, Lee HS, Huang GT, Yu CY, Lu FJ, Chow LP. J Proteome Res; 2005 Dec 08; 4(6):2062-9. PubMed ID: 16335951 [Abstract] [Full Text] [Related]
18. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer. Roblick UJ, Bader FG, Hammarstedt L, Habermann JK, Hellman U, Becker S, Sundmacker A, Gemoll T, Zimmermann K, Auer G, Munck-Wikland E. Acta Oncol; 2008 Dec 08; 47(8):1493-501. PubMed ID: 18759147 [Abstract] [Full Text] [Related]
19. Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation. Hood BL, Stewart NA, Conrads TP. Clin Lab Med; 2009 Mar 08; 29(1):115-38. PubMed ID: 19389555 [Abstract] [Full Text] [Related]